| scholarly article | Q13442814 |
| P2093 | author name string | A M Belkin | |
| D Krylov | |||
| S S Akimov | |||
| L F Fleischman | |||
| P2860 | cites work | Three-dimensional structure of a transglutaminase: human blood coagulation factor XIII | Q24564521 |
| Characterization of cDNA coding for human factor XIIIa | Q24629195 | ||
| Beta 1D integrin displaces the beta 1A isoform in striated muscles: localization at junctional structures and signaling potential in nonmuscle cells | Q28273706 | ||
| Gh: a GTP-binding protein with transglutaminase activity and receptor signaling function | Q28578829 | ||
| Affinity of human erythrocyte transglutaminase for a 42-kDa gelatin-binding fragment of human plasma fibronectin | Q36223387 | ||
| Expression of tissue transglutaminase in skeletal tissues correlates with events of terminal differentiation of chondrocytes | Q36233145 | ||
| Transglutaminase-catalyzed matrix cross-linking in differentiating cartilage: identification of osteonectin as a major glutaminyl substrate | Q36235525 | ||
| Muscle beta1D integrin reinforces the cytoskeleton-matrix link: modulation of integrin adhesive function by alternative splicing. | Q36255000 | ||
| Activation of distinct alpha5beta1-mediated signaling pathways by fibronectin's cell adhesion and matrix assembly domains | Q36255267 | ||
| beta1-integrin cytoplasmic subdomains involved in dominant negative function | Q36863689 | ||
| Peptides containing glutamine repeats as substrates for transglutaminase-catalyzed cross-linking: relevance to diseases of the nervous system | Q37045225 | ||
| Characterization of novel complexes on the cell surface between integrins and proteins with 4 transmembrane domains (TM4 proteins). | Q37379538 | ||
| Biosynthesis and acquisition of biological activity of the fibronectin receptor | Q38348191 | ||
| Tissue transglutaminase-dependent posttranslational modification of the retinoblastoma gene product in promonocytic cells undergoing apoptosis | Q40023599 | ||
| Transglutaminases | Q40082696 | ||
| Identification of a transforming growth factor-beta1/bone morphogenetic protein 4 (TGF-beta1/BMP4) response element within the mouse tissue transglutaminase gene promoter | Q41040397 | ||
| Regulated expression of tissue transglutaminase in Swiss 3T3 fibroblasts: effects on the processing of fibronectin, cell attachment, and cell death | Q41057277 | ||
| Reduced expression of tissue transglutaminase in a human endothelial cell line leads to changes in cell spreading, cell adhesion and reduced polymerisation of fibronectin. | Q41074541 | ||
| Identification and characterization of a versatile retinoid response element (retinoic acid receptor response element-retinoid X receptor response element) in the mouse tissue transglutaminase gene promoter | Q41226836 | ||
| Transfection of tissue transglutaminase into a highly malignant hamster fibrosarcoma leads to a reduced incidence of primary tumour growth. | Q41438808 | ||
| Localization of cellular transglutaminase on the extracellular matrix after wounding: characteristics of the matrix bound enzyme | Q41653086 | ||
| Regulation of transglutaminase type II by transforming growth factor-beta 1 in normal and transformed human epidermal keratinocytes. | Q41728326 | ||
| Transglutaminase-mediated processing of fibronectin by endothelial cell monolayers | Q42491069 | ||
| The binding sites on fibrin(ogen) for guinea pig liver transglutaminase are similar to those of blood coagulation factor XIII. Characterization of the binding of liver transglutaminase to fibrin | Q42650835 | ||
| Expression of tissue transglutaminase in Balb-C 3T3 fibroblasts: effects on cellular morphology and adhesion | Q42816111 | ||
| Transglutaminase action imitates Huntington's disease: selective polymerization of Huntingtin containing expanded polyglutamine. | Q45296134 | ||
| Isolation and characterization of cDNA clones to mouse macrophage and human endothelial cell tissue transglutaminases. | Q46233797 | ||
| A filter paper assay for transamidating enzymes using radioactive amine substrates | Q48024172 | ||
| Transglutaminase facilitates the formation of polymers of the beta-amyloid peptide | Q48088448 | ||
| Transglutaminase activity is increased in Alzheimer's disease brain | Q48762074 | ||
| Cross-linking of laminin-nidogen complexes by tissue transglutaminase. A novel mechanism for basement membrane stabilization | Q53857269 | ||
| Retinoic acid-induced expression of tissue transglutaminase in human promyelocytic leukemia (HL-60) cells. | Q53959200 | ||
| Transglutaminase stabilizes melanoma adhesion under laminar flow | Q54299547 | ||
| Transglutaminase-catalyzed crosslinking of fibrils of collagen V/XI in A204 rhabdomyosarcoma cells | Q58212968 | ||
| Localization of beta 1, beta 3, alpha 5, alpha v, and alpha IIb subunits of the integrin family in spreading human erythroleukemia cells | Q67666231 | ||
| Arrangement of cellular fibronectin in noncollagenous fibrils in human fibroblast cultures | Q67882033 | ||
| Tumor promoter and fibronectin induce actin stress fibers and focal adhesion sites in spreading human erythroleukemia (HEL) cells | Q68211548 | ||
| Complexation of fibronectin with tissue transglutaminase | Q69369367 | ||
| Differential expression of tissue transglutaminase in human cells. An immunohistochemical study | Q69371038 | ||
| Reversible unfolding of the gelatin-binding domain of fibronectin: structural stability in relation to function | Q69596833 | ||
| Identification of a substrate site for liver transglutaminase on the aminopropeptide of type III collagen | Q69892884 | ||
| Expression of tissue-type transglutaminase correlates positively with metastatic properties of human melanoma cell lines | Q72427940 | ||
| The fibronectin-binding domain of transglutaminase | Q72631476 | ||
| Transglutaminase-catalyzed cross-linking of osteopontin is inhibited by osteocalcin | Q73648523 | ||
| Fibronectin type III repeats mediate RGD-independent adhesion and signaling through activated beta1 integrins | Q73935017 | ||
| Distinct nuclear localization and activity of tissue transglutaminase | Q74516745 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | fibronectin-tissue transglutaminase complex | Q22327313 |
| alphaV-beta3 integrin-tissue transglutaminase complex | Q22327317 | ||
| alpha5-beta1 integrin-tissue transglutaminase complex | Q22327319 | ||
| alpha3-beta1 integrin-tissue transglutaminase complex | Q22327335 | ||
| alpha5-beta1 integrin-fibronectin-tissue transglutaminase complex | Q22327336 | ||
| alphaIIb-beta3 integrin-fibronectin-tissue transglutaminase complex | Q22327337 | ||
| alpha1-beta1 integrin-tissue transglutaminase complex | Q22327338 | ||
| P304 | page(s) | 825-38 | |
| P577 | publication date | 2000-02-21 | |
| P1433 | published in | Journal of Cell Biology | Q1524550 |
| P1476 | title | Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin | |
| P478 | volume | 148 |
| Q44104440 | 'Tissue' transglutaminase ablation reduces neuronal death and prolongs survival in a mouse model of Huntington's disease |
| Q51436143 | A Closed Chondromimetic Environment within Magnetic-Responsive Liquified Capsules Encapsulating Stem Cells and Collagen II/TGF-β3 Microparticles. |
| Q30547848 | A novel extracellular role for tissue transglutaminase in matrix-bound VEGF-mediated angiogenesis. |
| Q39051827 | A possible role of transglutaminase 2 in the nucleus of INS-1E and of cells of human pancreatic islets |
| Q57821053 | A small molecule regulator of tissue transglutaminase conformation inhibits the malignant phenotype of cancer cells |
| Q40645622 | Activation of in situ tissue transglutaminase by intracellular reactive oxygen species |
| Q34661302 | Activity-regulating structural changes and autoantibody epitopes in transglutaminase 2 assessed by hydrogen/deuterium exchange. |
| Q50554531 | An extracellular transglutaminase is required for apple pollen tube growth. |
| Q63225367 | Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac disease |
| Q37430981 | Antigen presentation in celiac disease. |
| Q29248440 | Astrocyte-derived tissue Transglutaminase affects fibronectin deposition, but not aggregation, during cuprizone-induced demyelination |
| Q34031863 | Astrocyte-derived tissue transglutaminase interacts with fibronectin: a role in astrocyte adhesion and migration? |
| Q42016431 | Beta-actin is a target for transglutaminase activity at synaptic endings in chicken telencephalic cell cultures |
| Q55499802 | Biological functionalities of transglutaminase 2 and the possibility of its compensation by other members of the transglutaminase family. |
| Q30499127 | Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells |
| Q38747102 | Celiac anti-type 2 transglutaminase antibodies induce differential effects in fibroblasts from celiac disease patients and from healthy subjects. |
| Q35082964 | Celiac anti-type 2 transglutaminase antibodies induce phosphoproteome modification in intestinal epithelial Caco-2 cells |
| Q47685543 | Celiac disease patient IgA antibodies induce endothelial adhesion and cell polarization defects via extracellular transglutaminase 2. |
| Q28082334 | Cell adhesion and long-term survival of transplanted mesenchymal stem cells: a prerequisite for cell therapy |
| Q34483657 | Cell surface transglutaminase promotes RhoA activation via integrin clustering and suppression of the Src-p190RhoGAP signaling pathway |
| Q74316537 | Cell-matrix interactions: the view from the outside |
| Q39657548 | Cellular Factor XIIIA Transglutaminase Localizes in Caveolae and Regulates Caveolin-1 Phosphorylation, Homo-oligomerization and c-Src Signaling in Osteoblasts |
| Q28260600 | Cellular functions of tissue transglutaminase |
| Q40068645 | Characterization of GPR56 protein and its suppressed expression in human pancreatic cancer cells |
| Q35921509 | Characterization of heparin-binding site of tissue transglutaminase: its importance in cell surface targeting, matrix deposition, and cell signaling |
| Q31114157 | Characterization of sea urchin transglutaminase, a protein regulated by guanine/adenine nucleotides |
| Q52585194 | Coeliac disease-specific autoantibodies targeted against transglutaminase 2 disturb angiogenesis. |
| Q34810240 | Coeliac disease: dissecting a complex inflammatory disorder |
| Q28550149 | Compensatory Increase of Transglutaminase 2 Is Responsible for Resistance to mTOR Inhibitor Treatment |
| Q80127956 | Complex formation between tissue transglutaminase II (tTG) and vascular endothelial growth factor receptor 2 (VEGFR-2): proposed mechanism for modulation of endothelial cell response to VEGF |
| Q39658648 | Contribution of celiac disease autoantibodies to the disease process |
| Q21560855 | Cytosolic guanine nucledotide binding deficient form of transglutaminase 2 (R580a) potentiates cell death in oxygen glucose deprivation |
| Q37870827 | Death and inflammation following somatic cell transplantation |
| Q34103330 | Delivering the message: epimorphin and mammary epithelial morphogenesis |
| Q36281324 | Dermatan sulfate is a player in the transglutaminase 2 interaction network |
| Q49967408 | Development of novel fluorescent particles applicable for phagocytosis assays with human macrophages |
| Q33396940 | Display of cell surface sites for fibronectin assembly is modulated by cell adherence to (1)F3 and C-terminal modules of fibronectin |
| Q48167266 | Dissecting the interaction between transglutaminase 2 and fibronectin |
| Q34109699 | Down-regulation of 5-HT1B and 5-HT1D receptors inhibits proliferation, clonogenicity and invasion of human pancreatic cancer cells |
| Q86759334 | Effect of retinoic acid and vitamin D3 on osteoblast differentiation and activity in aging |
| Q42369799 | Environmental Factors Contribute to β Cell Endoplasmic Reticulum Stress and Neo-Antigen Formation in Type 1 Diabetes |
| Q27305334 | Epidermal transglutaminase (TGase 3) is required for proper hair development, but not the formation of the epidermal barrier |
| Q34354765 | Erythrocytic transglutaminase inhibition hemolysis at presentation of celiac disease |
| Q37907975 | Evidences for a role of protein cross-links in transglutaminase-related disease. |
| Q28199362 | Evolution of transglutaminase genes: identification of a transglutaminase gene cluster on human chromosome 15q15. Structure of the gene encoding transglutaminase X and a novel gene family member, transglutaminase Z |
| Q36689540 | Evolutionary specialization of a tryptophan indole group for transition-state stabilization by eukaryotic transglutaminases |
| Q41585945 | Expression of the integrin coreceptor transglutaminase-2 in the RPE in vivo and in culture |
| Q81577578 | Expression of tissue transglutaminase in cultured bovine trabecluar meshwork cells |
| Q40462021 | External GTP-bound transglutaminase 2 is a molecular switch for chondrocyte hypertrophic differentiation and calcification. |
| Q35587161 | Extracellular TG2: emerging functions and regulation |
| Q53613303 | Extracellular calpains increase tubular epithelial cell mobility. Implications for kidney repair after ischemia. |
| Q36879220 | Extracellular tissue transglutaminase activates noncanonical NF-κB signaling and promotes metastasis in ovarian cancer |
| Q83099536 | Extracellular transglutaminase 2 has a role in cell adhesion, whereas intracellular transglutaminase 2 is involved in regulation of endothelial cell proliferation and apoptosis |
| Q33325485 | Extracellular transglutaminase 2 is catalytically inactive, but is transiently activated upon tissue injury |
| Q41994357 | Factor XIIIA mobilizes transglutaminase 2 to induce chondrocyte hypertrophic differentiation. |
| Q65000076 | Fibronectin in Layer-by-Layer Assembled Films Switches Tumor Cells between 2D and 3D Morphology. |
| Q40422808 | Fibronectin-tissue transglutaminase matrix rescues RGD-impaired cell adhesion through syndecan-4 and beta1 integrin co-signaling |
| Q34269343 | GPR56 in cancer progression: current status and future perspective |
| Q42004258 | GPR56 inhibits melanoma growth by internalizing and degrading its ligand TG2. |
| Q34731364 | GPR56 plays varying roles in endogenous cancer progression |
| Q24292757 | GPR56, an atypical G protein-coupled receptor, binds tissue transglutaminase, TG2, and inhibits melanoma tumor growth and metastasis |
| Q36207409 | Galectin-8 promotes cytoskeletal rearrangement in trabecular meshwork cells through activation of Rho signaling |
| Q31091532 | Gliadin T cell epitope selection by tissue transglutaminase in celiac disease. Role of enzyme specificity and pH influence on the transamidation versus deamidation process |
| Q33195266 | Gliadin and tissue transglutaminase complexes in normal and coeliac duodenal mucosa |
| Q34743996 | Glucose homeostasis in mice is transglutaminase 2 independent |
| Q37258548 | Heparan sulfate proteoglycans are receptors for the cell-surface trafficking and biological activity of transglutaminase-2. |
| Q28306935 | Hierarchies of extracellular matrix and mineral organization in bone of the craniofacial complex and skeleton |
| Q38327580 | Identification of a novel recognition sequence for fibronectin within the NH2-terminal beta-sandwich domain of tissue transglutaminase |
| Q44075214 | Identification of mammalian-type transglutaminase in Physarum polycephalum. Evidence from the cDNA sequence and involvement of GTP in the regulation of transamidating activity |
| Q33289840 | Identification of two GTP-independent alternatively spliced forms of tissue transglutaminase in human leukocytes, vascular smooth muscle, and endothelial cells |
| Q38824682 | Igs as Substrates for Transglutaminase 2: Implications for Autoantibody Production in Celiac Disease. |
| Q40322525 | Implications of increased tissue transglutaminase (TG2) expression in drug-resistant breast cancer (MCF-7) cells |
| Q40214283 | Importance of Ca(2+)-dependent transamidation activity in the protection afforded by tissue transglutaminase against doxorubicin-induced apoptosis |
| Q54636907 | Importance of syndecan-4 and syndecan -2 in osteoblast cell adhesion and survival mediated by a tissue transglutaminase-fibronectin complex. |
| Q55030374 | In vivo evaluation of two tissue transglutaminase PET tracers in an orthotopic tumour xenograft model. |
| Q34649501 | In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies. |
| Q42683546 | Increased TG2 expression can result in induction of transforming growth factor beta1, causing increased synthesis and deposition of matrix proteins, which can be regulated by nitric oxide |
| Q37142786 | Increased tissue transglutaminase activity contributes to central vascular stiffness in eNOS knockout mice. |
| Q37296940 | Induction of chondrogenic differentiation in mesenchymal stem cells by TGF-beta cross-linked to collagen-PLLA [poly(L-lactic acid)] scaffold by transglutaminase 2. |
| Q49509910 | Inhibition of YAP ameliorates choroidal neovascularization via inhibiting endothelial cell proliferation |
| Q33799573 | Inhibition of transglutaminase 2, a novel target for pulmonary fibrosis, by two small electrophilic molecules |
| Q90270614 | Inhibition of transglutaminase activity in periodontitis rescues periodontal ligament collagen content and architecture |
| Q38313373 | Inhibitory effect of tissue transglutaminase (tTG) antisense oligodeoxynucleotides on tTG expression in cultured bovine trabecular meshwork cells |
| Q28343531 | Interleukin-1 induces pro-mineralizing activity of cartilage tissue transglutaminase and factor XIIIa |
| Q43877859 | Involvement of tissue transglutaminase in the stabilisation of biomaterial/tissue interfaces important in medical devices |
| Q38962165 | Is monocyte- and macrophage-derived tissue transglutaminase involved in inflammatory processes? |
| Q92532015 | Loss of transglutaminase 2 sensitizes for diet-induced obesity-related inflammation and insulin resistance due to enhanced macrophage c-Src signaling |
| Q64086638 | Low Density Receptor-Related Protein 1 Interactions With the Extracellular Matrix: More Than Meets the Eye |
| Q37962503 | Matrix metalloproteinases and small artery remodeling |
| Q38166449 | Matrix regulation of idiopathic pulmonary fibrosis: the role of enzymes |
| Q58771165 | Mechanistic role of transglutaminase-2 in focal adhesions |
| Q36911913 | Membrane type 1-matrix metalloproteinase: substrate diversity in pericellular proteolysis |
| Q39628824 | Membrane-impermeable cross-linking provides evidence for homophilic, isoform-specific binding of desmosomal cadherins in epithelial cells |
| Q37541015 | Methylglyoxal in cells elicits a negative feedback loop entailing transglutaminase 2 and glyoxalase 1. |
| Q37687406 | Modification of mesenchymal stem cells for cardiac regeneration. |
| Q43093528 | Multi-factorial modulation of IGD motogenic potential in MSF (migration stimulating factor). |
| Q57295209 | New Insights into Development of Transglutaminase 2 Inhibitors as Pharmaceutical Lead Compounds |
| Q38865948 | Nitric oxide regulates non-classical secretion of tissue transglutaminase |
| Q35166534 | Nucleotide binding by the erythrocyte transglutaminase/Gh protein, probed with fluorescent analogs of GTP and GDP. |
| Q60950274 | Opening up about Tissue Transglutaminase: When Conformation Matters More than Enzymatic Activity |
| Q42800133 | Opposing roles of Ras/Raf oncogenes and the MEK1/ERK signaling module in regulation of expression and adhesive function of surface transglutaminase |
| Q38982831 | Optimizing stem cells for cardiac repair: Current status and new frontiers in regenerative cardiology |
| Q28261578 | Physiological, pathological, and structural implications of non-enzymatic protein-protein interactions of the multifunctional human transglutaminase 2 |
| Q30997344 | Plasma membrane factor XIIIA transglutaminase activity regulates osteoblast matrix secretion and deposition by affecting microtubule dynamics. |
| Q34399130 | Plasticity and stabilization of neuromuscular and CNS synapses: interactions between thrombin protease signaling pathways and tissue transglutaminase |
| Q53359651 | Protein kinase C activation stimulates mesenchymal stem cell adhesion through activation of focal adhesion kinase. |
| Q36040355 | Proteotranscriptomic Profiling of 231-BR Breast Cancer Cells: Identification of Potential Biomarkers and Therapeutic Targets for Brain Metastasis |
| Q34401105 | RGD-independent cell adhesion via a tissue transglutaminase-fibronectin matrix promotes fibronectin fibril deposition and requires syndecan-4/2 α5β1 integrin co-signaling |
| Q33871179 | Rapid interactome profiling by massive sequencing |
| Q35213282 | Reactivity of the N-terminal region of fibronectin protein to transglutaminase 2 and factor XIIIA |
| Q34055808 | Redox regulation of transglutaminase 2 activity |
| Q36066483 | Regulation of allergic lung inflammation by endothelial cell transglutaminase 2. |
| Q37269243 | Regulation of platelet-derived growth factor receptor function by integrin-associated cell surface transglutaminase |
| Q37378123 | Replication of celiac disease UK genome-wide association study results in a US population |
| Q46699463 | Retinoic acid receptors and tissue-transglutaminase mediate short-term effect of retinoic acid on migration and invasion of neuroblastoma SH-SY5Y cells |
| Q83186425 | RhoB is associated with the anti-angiogenic effects of celiac patient transglutaminase 2-targeted autoantibodies |
| Q35147626 | Role of tissue transglutaminase 2 in the acquisition of a mesenchymal-like phenotype in highly invasive A431 tumor cells. |
| Q38857583 | Role of tissue transglutaminase-2 (TG2)-mediated aminylation in biological processes. |
| Q28364936 | Role of transglutaminase II in retinoic acid-induced activation of RhoA-associated kinase-2 |
| Q36664166 | Roles of transglutaminases in cardiac and vascular diseases |
| Q37651981 | Secreted CLIC3 drives cancer progression through its glutathione-dependent oxidoreductase activity. |
| Q44556268 | Size distribution and molecular associations of plasma fibronectin and fibronectin crosslinked by transglutaminase 2. |
| Q90250923 | Small Molecules Target the Interaction between Tissue Transglutaminase and Fibronectin |
| Q28540004 | Small molecule inhibitors target the tissue transglutaminase and fibronectin interaction |
| Q61806085 | Spotlight on the Transglutaminase 2-Heparan Sulfate Interaction |
| Q38886629 | Strategies towards in vivo imaging of active transglutaminase type 2 using positron emission tomography |
| Q39414447 | Structural aspects of transglutaminase 2: functional, structural, and regulatory diversity |
| Q57465669 | Structure of natural variant transglutaminase 2 reveals molecular basis of gaining stability and higher activity |
| Q90632694 | Structures of Human Transglutaminase 2: Finding Clues for Interference in Cross-linking Mediated Activity |
| Q47730518 | Subcellular localization patterns of transglutaminase 2 in astrocytes and neurons are differentially altered by hypoxia |
| Q53764493 | Synthesis and Kinetic Characterisation of Water-Soluble Fluorogenic Acyl Donors for Transglutaminase 2. |
| Q37912042 | TG2, a novel extracellular protein with multiple functions |
| Q37187694 | TGM2 inhibition attenuates ID1 expression in CD44-high glioma-initiating cells |
| Q41881350 | The 45 kDa collagen-binding fragment of fibronectin induces matrix metalloproteinase-13 synthesis by chondrocytes and aggrecan degradation by aggrecanases. |
| Q48131187 | The Candida albicans ENO1 gene encodes a transglutaminase involved in growth, cell division, morphogenesis and osmotic protection. |
| Q26771338 | The Extracellular Matrix in Bronchopulmonary Dysplasia: Target and Source |
| Q64249805 | The Role of Tissue Transglutaminase in Cancer Cell Initiation, Survival and Progression |
| Q34794368 | The cellular proliferative phase of the wound repair process. |
| Q87593562 | The diamond anniversary of tissue transglutaminase: a protein of many talents |
| Q24338820 | The first draft of the endostatin interaction network |
| Q57937137 | The increased transglutaminase 2 expression levels during initial tumorigenesis predict increased risk of metastasis and decreased disease-free and cancer-specific survivals in renal cell carcinoma |
| Q24318943 | The interaction of angiocidin with tissue transglutaminase |
| Q50577776 | The interaction of heparan sulfate proteoglycans with endothelial transglutaminase-2 limits VEGF165-induced angiogenesis. |
| Q38336225 | The membrane form of the DNA repair protein Ku interacts at the cell surface with metalloproteinase 9. |
| Q35577299 | The metastatic tumor antigen 1-transglutaminase-2 pathway is involved in self-limitation of monosodium urate crystal-induced inflammation by upregulating TGF-β1 |
| Q38155423 | The plant extracellular transglutaminase: what mammal analogues tell |
| Q37061772 | The propensity for deamidation and transamidation of peptides by transglutaminase 2 is dependent on substrate affinity and reaction conditions |
| Q34613001 | The role of TG2 in regulating S100A4-mediated mammary tumour cell migration |
| Q39636385 | The role of tissue transglutaminase (TG2) in regulating the tumour progression of the mouse colon carcinoma CT26. |
| Q39651798 | The role of transglutaminase 2 and osteopontin in matrix protein supplemented microencapsulation of marrow stromal cells |
| Q41102349 | Tissue Transglutaminase Modulates Vascular Stiffness and Function Through Crosslinking-Dependent and Crosslinking-Independent Functions. |
| Q38311664 | Tissue array-based expression of transglutaminase-2 in human breast and ovarian cancer |
| Q41834313 | Tissue transgluaminase 2 expression in meningiomas |
| Q39268578 | Tissue transglutaminase (TG2) is involved in the resistance of cancer cells to the histone deacetylase (HDAC) inhibitor vorinostat. |
| Q54707844 | Tissue transglutaminase 2 as a biomarker of cervical intraepithelial neoplasia (CIN) and its relationship to p16INK4A and nuclear factor kappaB expression. |
| Q48151426 | Tissue transglutaminase expression is necessary for adhesion, metastatic potential and cancer stemness of renal cell carcinoma |
| Q40835429 | Tissue transglutaminase facilitates the polymerization of insulin-like growth factor-binding protein-1 (IGFBP-1) and leads to loss of IGFBP-1's ability to inhibit insulin-like growth factor-I-stimulated protein synthesis |
| Q47099586 | Tissue transglutaminase in astrocytes is enhanced by inflammatory mediators and is involved in the formation of fibronectin fibril-like structures |
| Q35193921 | Tissue transglutaminase in marmoset experimental multiple sclerosis: discrepancy between white and grey matter |
| Q34891045 | Tissue transglutaminase mediates the pro-malignant effects of oncostatin M receptor over-expression in cervical squamous cell carcinoma |
| Q38972352 | Tissue transglutaminase on trophoblast cells as a possible target of autoantibodies contributing to pregnancy complications in celiac patients |
| Q35535644 | Tissue transglutaminase promotes PDGF/PDGFR-mediated signaling and responses in vascular smooth muscle cells |
| Q36916874 | Tissue transglutaminase protects epithelial ovarian cancer cells from cisplatin-induced apoptosis by promoting cell survival signaling |
| Q40685188 | Tissue transglutaminase regulates chondrogenesis in mesenchymal stem cells on collagen type XI matrices |
| Q52365303 | Tissue transglutaminase regulates interactions between ovarian cancer stem cells and the tumor niche. |
| Q42626618 | Tissue transglutaminase, coagulation factor XIII, and the pro-polypeptide of von Willebrand factor are all ligands for the integrins alpha 9beta 1 and alpha 4beta 1. |
| Q36916421 | Tissue transglutaminase-2 promotes gastric cancer progression via the ERK1/2 pathway |
| Q36503511 | Tissue transglutaminase: a new target to reverse cancer drug resistance |
| Q42532763 | Tissue-specific responses to loss of transglutaminase 2. |
| Q47231818 | Transglutaminase 2 Promotes Migration and Invasion of Lung Cancer Cells |
| Q38855195 | Transglutaminase 2 and Transglutaminase 2 Autoantibodies in Celiac Disease: a Review |
| Q35527871 | Transglutaminase 2 and its role in pulmonary fibrosis. |
| Q37434321 | Transglutaminase 2 as a novel activator of LRP6/β-catenin signaling |
| Q36633284 | Transglutaminase 2 cross-linking activity is linked to invadopodia formation and cartilage breakdown in arthritis |
| Q39168249 | Transglutaminase 2 expression in acute myeloid leukemia: association with adhesion molecule expression and leukemic blast motility |
| Q38648421 | Transglutaminase 2 in cancer |
| Q48372615 | Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy. |
| Q35989247 | Transglutaminase 2 inhibitors and their therapeutic role in disease states |
| Q34161250 | Transglutaminase 2 inhibits apoptosis induced by calcium- overload through down-regulation of Bax |
| Q58064967 | Transglutaminase 2 interactions with extracellular matrix proteins as probed with celiac disease autoantibodies |
| Q37702089 | Transglutaminase 2 is essential for adherence of Porphyromonas gingivalis to host cells |
| Q35697155 | Transglutaminase 2 is secreted from smooth muscle cells by transamidation-dependent microparticle formation |
| Q92236086 | Transglutaminase 2 limits the extravasation and the resultant myocardial fibrosis associated with factor XIII-A deficiency |
| Q38682039 | Transglutaminase 2 modulation of NF-κB signaling in astrocytes is independent of its ability to mediate astrocytic viability in ischemic injury |
| Q34994693 | Transglutaminase 2 overexpression in tumor stroma identifies invasive ductal carcinomas of breast at high risk of recurrence |
| Q35119936 | Transglutaminase 2 regulates early chondrogenesis and glycosaminoglycan synthesis. |
| Q30152720 | Transglutaminase 2 strongly binds to an extracellular matrix component other than fibronectin via its second C-terminal beta-barrel domain |
| Q21092747 | Transglutaminase 2 undergoes a large conformational change upon activation |
| Q27027862 | Transglutaminase 2-mediated serotonylation in pulmonary hypertension |
| Q37057882 | Transglutaminase 2-specific autoantibodies in celiac disease target clustered, N-terminal epitopes not displayed on the surface of cells |
| Q35693361 | Transglutaminase 2: a molecular Swiss army knife |
| Q38736793 | Transglutaminase Interaction with α6/β4-Integrin Stimulates YAP1-Dependent ΔNp63α Stabilization and Leads to Enhanced Cancer Stem Cell Survival and Tumor Formation. |
| Q38269678 | Transglutaminase as a therapeutic target for celiac disease |
| Q46561808 | Transglutaminase crosslinking of SIBLING proteins in teeth |
| Q42506814 | Transglutaminase inhibitors induce hyperproliferation and parakeratosis in tissue-engineered skin. |
| Q33707936 | Transglutaminase regulation of cell function. |
| Q41898516 | Transglutaminase type II plays a protective role in hepatic injury |
| Q37224569 | Transglutaminase-2 Is Involved in All-Trans Retinoic Acid-Induced Invasion and Matrix Metalloproteinases Expression of SH-SY5Y Neuroblastoma Cells via NF-κB Pathway |
| Q92219315 | Transglutaminase-2 Mediates the Biomechanical Properties of the Colorectal Cancer Tissue Microenvironment that Contribute to Disease Progression |
| Q24309155 | Transglutaminase-2 interaction with heparin: identification of a heparin binding site that regulates cell adhesion to fibronectin-transglutaminase-2 matrix |
| Q40760483 | Transglutaminase-2: a new endostatin partner in the extracellular matrix of endothelial cells |
| Q42243895 | Transglutaminase-mediated oligomerization of the fibrin(ogen) alphaC domains promotes integrin-dependent cell adhesion and signaling. |
| Q39652140 | Transglutaminase-mediated oligomerization promotes osteoblast adhesive properties of osteopontin and bone sialoprotein |
| Q37944145 | Transglutaminases and receptor tyrosine kinases. |
| Q48305796 | Transglutaminases factor XIII-A and TG2 regulate resorption, adipogenesis and plasma fibronectin homeostasis in bone and bone marrow |
| Q37062778 | Transglutaminases in vascular biology: relevance for vascular remodeling and atherosclerosis. |
| Q35058528 | Transglutaminases: crosslinking enzymes with pleiotropic functions |
| Q44811427 | Transglutaminases: future perspectives. |
| Q37981102 | Transglutaminases: key regulators of cancer metastasis. |
| Q24534936 | Transglutaminases: nature's biological glues |
| Q33893946 | Unconventional secretion of tissue transglutaminase involves phospholipid-dependent delivery into recycling endosomes |
| Q39950392 | Use of tissue transglutaminase and fibronectin to influence osteoblast responses to tricalcium phosphate scaffolds. |
| Q41585904 | αvβ5 integrin-dependent diurnal phagocytosis of shed photoreceptor outer segments by RPE cells is independent of the integrin coreceptor transglutaminase-2. |
| Q38637035 | β cell ER stress and the implications for immunogenicity in type 1 diabetes |
Search more.